Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Capricor, NextCure shed light on recent layoffs
Capricor and NextCure have shed light on recent rounds of layoffs, as the biotechs brace for a hoped-for drug approval and merger, respectively.
James Waldron
Nov 11, 2026 4:48am
Why scientific progress depends on knowing when to look again
Brought to you by
Ipsen
Beam’s sickle cell results signal Casgevy, Lyfgenia showdown
Nov 10, 2026 3:19pm
How Virtual Control Groups Are Shaping Safety Studies
Brought to you by
Charles River Laboratories
Fierce Healthcare
Oura to acquire AI virtual care partner Counsel Health for $625M
Nov 10, 2026 3:09pm
PepGen’s stock doubles as midphase DM1 data wow analysts
Nov 10, 2026 10:21am
More News
AstraZeneca buys partner Omniose for bacterial vaccine tech
Nov 10, 2026 10:16am
Fierce Biotech Fundraising Tracker '26: Oyster, Delix & more
Nov 10, 2026 10:00am
Mirum scores again in hep D phase 3, setting up FDA run
Nov 10, 2026 10:00am
Why experts fear fallout from Treasury’s China biotech crackdown
Nov 10, 2026 9:30am
See more stories